NGFR (CD271) is a marker of SHH medulloblastoma, and CD271+ medulloblastoma cells exhibit increased Ras/MAPK signaling, invasion, and migration which can be successfully targeted with MEK inhibition. This evidence concerns the gene MAP2K7 and medulloblastoma.